Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways
Zhiyun Wei, Xingjun Meng, Rachid El Fatimy, et al.
Neurobiology of Disease (2019) Vol. 134, pp. 104617-104617
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

RETRACTED: Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model
Karolina J. Janczura, Claude‐Henry Volmar, Gregory C. Sartor, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 47
Open Access | Times Cited: 176
Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
Elena Tamagno, Michela Guglielmotto, Valeria Vasciaveo, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1479-1479
Open Access | Times Cited: 143
Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity
Nagendran Ramalingam, Shan‐Xue Jin, Tim E. Moors, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 67
The concept of resilience to Alzheimer’s Disease: current definitions and cellular and molecular mechanisms
Luuk E. de Vries, Inge Huitinga, Helmut W. Kessels, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 21
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 89
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 46
Dendritic Spine and Synaptic Plasticity in Alzheimer’s Disease: A Focus on MicroRNA
Edwin E. Reza-Zaldívar, Mercedes A. Hernández-Sapiéns, Benito Minjarez, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 58
Alzheimer’s Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target
Meng Zhang, Zhigang Bian
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 41
microRNA-132 regulates gene expression programs involved in microglial homeostasis
Hannah Walgrave, Amber Penning, Giorgia Tosoni, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106829-106829
Open Access | Times Cited: 21
Cognitive epigenetic priming: leveraging histone acetylation for memory amelioration
Allison M. Burns, Johannes Gräff
Current Opinion in Neurobiology (2020) Vol. 67, pp. 75-84
Open Access | Times Cited: 49
Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer’s Disease
Bhanu Chandra Karisetty, Akanksha Bhatnagar, Ellen M. Armour, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 49
The mechanism of enriched environment repairing the learning and memory impairment in offspring of prenatal stress by regulating the expression of activity-regulated cytoskeletal-associated and insulin-like growth factor-2 in hippocampus
Suzhen Guan, Youjuan Fu, Feng Zhao, et al.
Environmental Health and Preventive Medicine (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 35
The Molecular Effects of Environmental Enrichment on Alzheimer’s Disease
Anthony Kin Yip Liew, Chuin Hau Teo, Tomoko Soga
Molecular Neurobiology (2022) Vol. 59, Iss. 12, pp. 7095-7118
Open Access | Times Cited: 25
Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies
Ajmal Nassar, Sairaj Satarker, Prasada Chowdari Gurram, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5557-5577
Open Access | Times Cited: 14
MicroRNAs and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy
Amir Hossein Mohammadi, Seyedvahid Seyedmoalemi, Mahsa Moghanlou, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 8, pp. 5084-5102
Closed Access | Times Cited: 20
β-pinene ameliorates ICV-STZ induced Alzheimer’s pathology via antioxidant, anticholinesterase, and mitochondrial protective effects: In-silico and in-vivo studies
Mini Dahiya, Anil Kumar, Monu Yadav, et al.
European Journal of Pharmacology (2025), pp. 177307-177307
Closed Access
Therapeutic modulation of neurogenesis to improve hippocampal plasticity and cognition in aging and Alzheimer's disease
MOSTAFA MOSTAFA, Ahmed Disouky, Orly Lazarov
Neurotherapeutics (2025), pp. e00580-e00580
Open Access
AhR Ligands Differentially Regulate miRNA-132 Which Targets HMGB1 and to Control the Differentiation of Tregs and Th-17 Cells During Delayed-Type Hypersensitivity Response
Osama A. Abdulla, Wurood Hantoosh Neamah, Muthanna Sultan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Bidirectional modulation of neural plasticity by self-powered neural stimulation
Tianming Zhao, Yechao Han, Liuni Qin, et al.
Nano Energy (2021) Vol. 85, pp. 106006-106006
Closed Access | Times Cited: 19
Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer’s disease
Chong Zeng, Xingjun Meng, Dongmei Mai, et al.
Behavioural Brain Research (2021) Vol. 417, pp. 113584-113584
Closed Access | Times Cited: 18
miRNA‐137‐5p improves spatial memory and cognition in Alzheimer's mice by targeting ubiquitin‐specific peptidase 30
Yang Jiang, Wei Bian, Jing Chen, et al.
Animal Models and Experimental Medicine (2023) Vol. 6, Iss. 6, pp. 526-536
Open Access | Times Cited: 7
Histone deacetylase in neuropathology
Rohan Gupta, Rashmi K. Ambasta, Pravir Kumar
Advances in clinical chemistry (2020), pp. 151-231
Closed Access | Times Cited: 20
Identification of potential therapeutic and diagnostic characteristics of Alzheimer disease by targeting the miR-132-3p/FOXO3a-PPM1F axis in APP/PS1 mice
Xiaofeng Fu, Jing Liu, Junjie Xie, et al.
Brain Research (2022) Vol. 1790, pp. 147983-147983
Closed Access | Times Cited: 12
NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer’s disease
Amber Penning, Sarah Snoeck, Oxana Garritsen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Dysregulated CRTC1-BDNF signaling pathway in the hippocampus contributes to Aβ oligomer-induced long-term synaptic plasticity and memory impairment
Peiyun Yan, Zhancheng Xue, Li D, et al.
Experimental Neurology (2021) Vol. 345, pp. 113812-113812
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top